Castle Biosciences Inc (CSTL)

May 05, 2026

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know - Yahoo Finance Singapore

May 05, 2026

May 05, 2026

Free skin cancer screenings roll out nationwide with Castle support - Stock Titan

May 05, 2026

May 04, 2026

Castle Biosciences to present new Mayo Clinic research on TissueCypher test at Digestive Disease Week - Traders Union

May 04, 2026

May 04, 2026

Mayo Clinic data: Barrett's test changed surveillance in 55% - Stock Titan

May 04, 2026

May 02, 2026

Castle Biosciences, Inc. $CSTL Shares Sold by AIGH Capital Management LLC - MarketBeat

May 02, 2026

May 01, 2026

(CSTL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

May 01, 2026

Apr 30, 2026

Earnings Preview: CSTL to Report Financial Results Post-market on May 06 - Moomoo

Apr 30, 2026

Apr 29, 2026

Castle Biosciences (NASDAQ:CSTL) Upgraded to Strong-Buy at Zacks Research - MarketBeat

Apr 29, 2026

Apr 29, 2026

Castle Biosciences (CSTL) to Release Earnings on Wednesday - MarketBeat

Apr 29, 2026

Apr 27, 2026

What makes Castle Biosciences (CSTL) a good fit for 'trend investing' - MSN

Apr 27, 2026

Apr 24, 2026

Castle Biosciences (NASDAQ:CSTL) Shares Gap Down on Insider Selling - MarketBeat

Apr 24, 2026

Apr 24, 2026

Castle Biosciences to Release First Quarter 2026 Financial Resul - GuruFocus

Apr 24, 2026

Apr 23, 2026

Castle Biosciences CEO Maetzold sells $104,708 in shares By Investing.com - Investing.com Australia

Apr 23, 2026

Apr 23, 2026

Castle Biosciences (NASDAQ:CSTL) Insider Sells $90,912.20 in Stock - MarketBeat

Apr 23, 2026

Apr 23, 2026

Castle Biosciences (NASDAQ: CSTL) CEO sells 4,172 shares via trusts - Stock Titan

Apr 23, 2026

Apr 22, 2026

CSTL (Castle Biosciences Inc.) reports narrower than expected Q4 2025 loss and slight revenue growth, lifting shares modestly.Open Stock Signal Network - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 22, 2026

Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS - The Malaysian Reserve

Apr 22, 2026

Apr 22, 2026

Castle Biosciences to present melanoma test data at conferences By Investing.com - Investing.com India

Apr 22, 2026

Apr 21, 2026

Castle Biosciences to present melanoma test data at conferences - Investing.com

Apr 21, 2026

Apr 21, 2026

New data suggest some early melanomas carry higher relapse risk - Stock Titan

Apr 21, 2026

Apr 20, 2026

Laboratory teams drive progress in skin cancer diagnostics at Castle Biosciences - Traders Union

Apr 20, 2026

Apr 20, 2026

CSTL Maintained by Canaccord Genuity -- Price Target Lowered to $40 - GuruFocus

Apr 20, 2026

Apr 20, 2026

(CSTL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Apr 20, 2026

Apr 17, 2026

Castle Biosciences, Inc. (CSTL) Stock Analysis: A 97% Upside Potential Beckons Investors - DirectorsTalk Interviews

Apr 17, 2026

Apr 17, 2026

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Apr 17, 2026

Apr 16, 2026

Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026 - Sahm

Apr 16, 2026

Apr 15, 2026

Castle Biosciences inks expansion at Nova Place - WPXI

Apr 15, 2026

Apr 15, 2026

After the close on May 6, Castle Biosciences will break down Q1 - Stock Titan

Apr 15, 2026

Apr 13, 2026

Castle Biosciences inks expansion at Nova Place on North SidePittsburgh Business Times - The Business Journals

Apr 13, 2026

Apr 11, 2026

Aug EndMonth: How sensitive is Castle Biosciences Inc to inflationShare Buyback & AI Enhanced Trading Signals - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Castle Biosciences (NASDAQ:CSTL) Shares Down 7%What's Next? - MarketBeat

Apr 10, 2026

Apr 10, 2026

Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year - Bitget

Apr 10, 2026

Apr 09, 2026

Castle Biosciences, Inc.Common stock (NQ: CSTL - The Chronicle-Journal

Apr 09, 2026

Apr 09, 2026

Castle Biosciences CEO sells shares worth $246,195 By Investing.com - Investing.com Australia

Apr 09, 2026

Apr 09, 2026

Breakouts Watch: Does Castle Biosciences Inc have declining or rising EPSEarnings Miss & Fast Gain Swing Alerts - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Ideas Watch: Can Castle Biosciences Inc deliver alphaWeekly Trade Report & AI Forecasted Stock Moves - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 6,214 Shares of Stock - MarketBeat

Apr 08, 2026

Apr 08, 2026

Castle Biosciences CEO sells shares worth $246,195 - Investing.com

Apr 08, 2026

Apr 08, 2026

Castle Biosciences (CSTL) CEO pre-planned sale of 9,836 shares after option exercise - Stock Titan

Apr 08, 2026

Apr 08, 2026

Strong 2025 revenue and governance focus in Castle Biosciences (CSTL) proxy - Stock Titan

Apr 08, 2026

Apr 08, 2026

Castle Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer MAETZOLD DEREK J - Moomoo

Apr 08, 2026

Apr 06, 2026

Castle Biosciences, Inc. (CSTL) stock price, news, quote and history - Yahoo Finance Singapore

Apr 06, 2026

Apr 05, 2026

Castle Biosciences, Inc. (CSTL) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 05, 2026

Apr 05, 2026

AI Stocks: Can Castle Biosciences Inc maintain its current growth rate2026 Highlights & Daily Price Action Insights - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

How Revenue Assumptions Are Rewriting The Story For Castle Biosciences (CSTL) - Yahoo Finance

Apr 04, 2026

Apr 01, 2026

CSTL PE Ratio & Valuation, Is CSTL Overvalued - Intellectia AI

Apr 01, 2026

Mar 31, 2026

CSTL SEC FilingsCastle Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 31, 2026